Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28739896)

Published in Proc Natl Acad Sci U S A on July 24, 2017

Authors

Nikolaos M Nikolaidis1, John G Noel2, Lori B Pitstick3, Jason C Gardner3,2, Yasuaki Uehara3, Huixing Wu3, Atsushi Saito3, Kara E Lewnard3, Huan Liu3, Mitchell R White4, Kevan L Hartshorn4, Francis X McCormack1

Author Affiliations

1: Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267; nikolan@uc.edu MCCORMFX@UCMAIL.UC.EDU.
2: Department of Research, Shriner's Hospital for Children, Cincinnati, OH 45229.
3: Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267.
4: Department of Medicine, Boston University School of Medicine, Boston, MA 02118.

Articles cited by this

Avian flu: influenza virus receptors in the human airway. Nature (2006) 11.28

The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05

Estimates of deaths associated with seasonal influenza --- United States, 1976-2007. MMWR Morb Mortal Wkly Rep (2010) 7.04

H5N1 Virus Attachment to Lower Respiratory Tract. Science (2006) 6.34

Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med (2004) 6.26

Clinical signs and symptoms predicting influenza infection. Arch Intern Med (2000) 5.83

The pathology of influenza virus infections. Annu Rev Pathol (2008) 5.37

Human host factors required for influenza virus replication. Nature (2010) 5.28

Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol (2002) 5.09

Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology (1999) 5.07

Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol (2007) 4.86

The type 2 cell as progenitor of alveolar epithelial regeneration. A cytodynamic study in mice after exposure to oxygen. Lab Invest (1974) 4.21

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35

Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell (2011) 3.00

Assembly and budding of influenza virus. Virus Res (2004) 2.90

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine (2002) 2.69

Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A (2006) 2.63

The biology of influenza viruses. Vaccine (2008) 2.58

Influenza A viruses target type II pneumocytes in the human lung. J Infect Dis (2012) 2.38

Cell proliferation in the mammalian lung. Int Rev Exp Pathol (1980) 2.31

Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure. Crit Care Med (2014) 2.07

Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol (2006) 1.94

N-linked glycosylation attenuates H3N2 influenza viruses. J Virol (2007) 1.92

Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase. J Med Chem (2011) 1.88

Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. Am J Respir Cell Mol Biol (2002) 1.85

Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol (2001) 1.79

The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells. PLoS Pathog (2010) 1.73

Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res (2003) 1.70

Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J Clin Invest (1995) 1.68

Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. N Engl J Med (1982) 1.60

Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis (2013) 1.55

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax (2012) 1.40

Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol (2004) 1.35

Keratinocyte growth factor reduces lung damage due to acid instillation in rats. Am J Respir Cell Mol Biol (1996) 1.32

Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol (2002) 1.29

Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am J Pathol (1999) 1.19

Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc Assoc Am Physicians (1997) 1.17

Smoking and epidemic influenza-like illness in female military recruits: a brief survey. Am J Public Health (1981) 1.15

Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis (2006) 1.14

Pulmonary surfactant protein a inhibits macrophage reactive oxygen intermediate production in response to stimuli by reducing NADPH oxidase activity. J Immunol (2004) 1.11

Hijacking of the host-cell response and translational control during influenza virus infection. Virus Res (2006) 1.01

Pregnancy and infection. N Engl J Med (2014) 0.99

Intravenous keratinocyte growth factor protects against experimental pulmonary injury. Am J Physiol (1998) 0.96

Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages. J Biol Chem (2011) 0.95

Respiratory tract infections: another reason not to smoke. Cleve Clin J Med (2005) 0.95

Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo. J Biol Chem (2011) 0.91

The amazing innate immune response to influenza A virus infection. Innate Immun (2013) 0.91

Influence of increased oxygenation on influenza virus infection in mice. Lancet (1961) 0.89

PM2.5 in Beijing - temporal pattern and its association with influenza. Environ Health (2014) 0.86

Cell proliferation in lungs of mice exposed to elevated concentrations of oxygen. Aerosp Med (1972) 0.82

Regenerative response of the rat tracheal epithelium after acute exposure to tobacco smoke: a quantitative study. J Natl Cancer Inst (1975) 0.77

Palifermin, a recombinant human keratinocyte growth factor, triggers reactivation of anogenital human papillomavirus infection in a HIV-positive patient with diffuse large cell B-cell non-Hodgkin lymphoma. Bone Marrow Transplant (2009) 0.77

Keratinocyte growth factor supports pulmonary innate immune defense through maintenance of alveolar antimicrobial protein levels and macrophage function. Am J Physiol Lung Cell Mol Physiol (2016) 0.75